Good morning, everyone, and welcome to Olin Corporation's first quarter 2024 earnings conference call. All participants will be in a listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. Following today's brief opening comments, there will be an opportunity to ask questions. To ask a question, you may press star and one on a touch-tone telephone. To withdraw your questions, you may press star and two. Please also note today's event is being recorded. At this time, I'd like to turn the floor over to Steve Keenan, Olin's Director of Investor Relations. Please go ahead, Steve. Thank you, Operator. Good morning, everyone, and thank you for joining us today. Before we begin, let me remind you that this discussion, along with the associated slides and the question-and-answer session that follows, will include statements regarding estimates or expectations of future performance. Please note that these are forward-looking statements and that actual results could differ materially from those projected. Some of the factors that could cause actual results to differ from our projections are described without limitations in the risk factors section of our most recent Form 10-K and in yesterday's first quarter earnings press release. A copy of today's transcript and slides will be available on our website in the investor section under past events. Our earnings press release and other financial data and information are available under press releases. With me this morning are Ken Lane, Olin CEO, and Todd Slater, Olin CFO. We'll begin with our prepared remarks, and thereafter we'll be happy to take your questions. I'll now turn the call over to Ken Lane. Ken? Thank you, Steve. Good morning, everyone. Let me start by saying I'm delighted to be part of Team Olin. Olin has a long and rich history with leading positions across its portfolio, and I'm looking forward to leading the company as we define the next phase of value creation for our shareholders and employees. Today, Olin is in great shape with an investment-grade balance sheet and a strong team. This company has incredible potential, and I look forward, together with our 7,000 Olin team members, to start building upon this foundation and writing the next chapter in Olin's success story. I do want to thank Scott Sutton for his leadership of the company, which resulted in a step change of record results. Scott has been very gracious with his time and support during our transition. I'm a firm believer in our operating model, and I am absolutely committed to continuing Olin's value-focused commercial approach. The entire Olin team embraces the winning model, and that support runs deep, from senior leadership to frontline manufacturing. Now I want to talk about my near-term priorities. First and foremost is always operating safely. Keeping our people and our community safe while running our assets efficiently and reliably. It is not a coincidence that the safest operators are the most reliable, and we are focused on being a leader with respect to our safety performance. Next, Olin is a coiled spring, and as our market demand recovers and customers seek to pull more volume, we'll be ready to capture that significant value opportunity. I'll provide whatever support is needed to defend the gains we have achieved and continue our value generation as the industry leader that we are. Also, it's clear to me that investors appreciate Olin's consistently strong cash flow and share buybacks across the cycle. Delivering on our commitments is an imperative. We will continue our disciplined capital allocation strategy and will be a steady buyer of our shares, focused on delivering above-average shareholder returns. Finally, I'm committed to providing Olin stakeholders with strategic transparency and a long-term roadmap for growth that we will share during a capital markets day around year-end. More will be communicated on that in the near future. Now let's take a quick look at our Chlor Alkali business and turn to slide 5. Olin took decisive actions during the fourth quarter to curb price erosion across our system. Early in the first quarter, our Value Accelerator initiative continued to tighten Olin supply, successfully advancing the inflection point and effectively stopping the value drop. During the first quarter, we saw improved chlorine volume being pulled by Olin customers at our value level across several key end uses, including agriculture, urethanes, titanium dioxide, and water treatment. As we look beyond the first quarter, we are seeing some seasonal demand increases for chlorine and caustic soda. In the United States, planned and unplanned outages and low supplier inventories have kept caustic availability tighter than expected. Trade publications confirm that domestic caustic is climbing up from a cycle bottom. Now let's turn to our epoxy business on slide 6. During the first quarter, our epoxy business continued to realize the benefits of our 2023 restructuring actions. Our streamlined asset base will support the growth of our higher-margin epoxy systems demand while also reducing Olin's downside commodity exposure across the cycle. Our recently announced U.S. anti-dumping initiative seeks to level the playing field. The first quarter marks the beginning of the recovery for epoxy and the start of a gradual climb out of a very deep trough. As that building momentum continues into the second quarter, we will realize continued benefits from our restructuring and stronger focus on higher-margin formulated systems. Please turn to slide 7 for a Winchester recap. First quarter commercial ammunition demand was good, and our military segment continues to be strong, delivering sequential Adjusted EBITDA growth for the fourth quarter. We are concerned that propellant shortages could limit commercial ammunition supply this year, and we're actively working on mitigation. Our integration of the White Flyer business has exceeded expectations and is a great addition to our Winchester business, the leading brand in the industry and a strong cash flow generator for Olin. During the second quarter, Olin expects to break ground on the Army's Next Generation Squad Weapon ammunition plant. This will be the world's most transformational small-caliber ammunition plant ever built. This project will be designed, built, and operated by Winchester but funded and owned by the U.S. Army. Before I pass it to Todd to review our financials, I'll sum up by saying this: Olin's future is bright, but we must remain disciplined and dedicated to extending our leadership position. Olin has led through the trough, seeding volume to maintain value. As demand recovers, we are well-positioned to profitably capture the market recovery. We have reset the cycle, and we will continue to lead with discipline to ensure that this new normal remains durable. The Olin assets and operating model provide an extraordinary foundation to build upon. I've had the opportunity over the last month to visit many of our sites and meet with many of our team members. Olin is well-run, well-funded, and with a highly engaged and committed team, we will continue to generate differential shareholder value. I'll now pass it over to Todd for a few financial highlights. Thanks, Ken. Olin was in great financial shape headed into this manufacturing recessionary environment we've been experiencing over the last year and a half. Our rock-solid financial foundation is a key pillar of Olin's winning model. We remain committed to maintaining our investment-grade balance sheet and achieving additional investment-grade credit ratings. On March 31, 2024, we ended the first quarter with $150.9 million of cash and cash equivalents and approximately $1.2 billion of available liquidity. As we expected, our net debt increased by approximately $115 million from year-end, primarily due to the typical seasonal increase in working capital. Our quarter-end net debt-to-Adjusted EBITDA ratio was 2.3x, which we expect to return to the 2x range by later this year. Our 2024 cash flow projection anticipates a couple of unusual cash usage items totaling approximately $130 million. Our 2024 cash tax rate is forecast to be higher than normal due to deferred international tax payments of approximately $80 million that are forecast to be paid later this year. Also, we are expecting the final payments under long-term energy supply contracts of approximately $50 million. Excluding these one-time items, our 2024 Levered Free Cash Flow yield currently would equate to approximately 10%. Finally, our Investment-grade balance sheet and cash flow should enable Olin to continue to deploy a substantial portion of our 2024 Levered Free Cash Flow toward share repurchases. Operator, we are now ready to take questions. Ladies and gentlemen, we'll now begin the question-and-answer session. To ask a question, you may press star and one on your touch-tone phones. If you are using a speakerphone, we do ask that you please pick up your handset prior to pressing the keys to ensure the best sound quality. To withdraw your questions, you may press star and two. Again, that is star and then one to ask a question. We'll pause momentarily to assemble the roster. And our first question today comes from Hassan Ahmed from Alembic Global. Please go ahead with your question. Morning, Ken. And first of all, congratulations on the new role. My question is first and foremost on the 2024 initial guidance that you've provided. You're obviously guiding to north of $1.3 billion in EBITDA. I mean, if we were to sort of take Q1 reported EBITDA as, call it, a starting point, the $242 million, annualize that, you're at $970 million, right? And you're guiding to 2024 EBITDA north of $1.3. So what gets us what bridges us to that $1.3 billion, that incremental, call it, $340 million or so? I mean, my guess is, and I'd love to hear your views, that you guys had historically talked about the Value Accelerator initiative being maybe a $100 million quarterly penalty. Is it primarily that? Hi, Hassan. Thank you for the congratulations. Yeah, listen, what we have seen in the first quarter is we were successful in stopping the drop, at least in the chlor-alkali and product vinyls group. So that's a win for us. What we see happening now, though, is seasonal demand is coming back, so we are seeing good momentum. The other thing that I'll say is, when you think about the full year, what we've said previously is we're going to see better performance in the epoxy business as well as Winchester. So let's not forget that. So as we see both of those businesses continue to improve year-over-year, chlor-alkali is going to continue to improve as we go into the second half of the year. We are seeing some positive signs for demand in the back half of the year with some requests for volume. So I think with the higher results that we expect from Epoxy at Winchester and the momentum that we see from chlor-alkali, we should see that flat to slightly higher results for 2024. That's how we get there. Understood. Understood. As a follow-up, you touched on the improvement sequentially within the epoxy business. How should we think about the split between, call it, further organic improvement over there? And maybe you could touch a bit on some of these sort of trade cases that you guys as well as the industry has brought about on the anti-dumping side of things. Yeah, so we are seeing the impact from the restructuring last year. The team did a great job last year right-sizing the footprint. We've got the asset footprint that we think is going to support the strategy around growing the higher-margin business today. But we are seeing an influx over the last year or so of product that is being dumped into the United States. First, I'll say we're all for fair trade, free trade, but we're going to fight against unfair trade, and that's what you see here. So we had the first hearings in Washington, D.C., this week. It's early in that process, but we're going to continue to push that case. And we believe that there is a risk within the United States having only two producers of epoxy resin is a risk for the future. We've got a very critical material here that we're producing, and it is under threat by unfair trade. Very helpful, Ken. Thank you so much. Thank you, Hasan. Our next question comes from Alexei Yefremov from KeyBanc Capital Markets. Please go ahead with your question. Thanks. Good morning, all. And, Ken, congratulations as well. I was just hoping to get some details, any specific details, really, on how you're getting to $1.3 billion EBITDA this year. And in particular, are you assuming price increases in caustic soda, chlorine, EDC, any other major commodities in your chlorovinyls business? And how do they compare to Chemical Market Analytics forecasts? Is Chemical Market Analytics forecast sufficient, or do you need to get something more than that? Well, thank you, Alexei. Going back to what I had said to Hassan, let's not forget about the improvements that we're going to see in Winchester and epoxy year-over-year. Both of those businesses are going to improve. We're seeing very strong demand with Winchester. We're making good progress with our price initiatives there as well, even to offset some of the cost headwinds that we see. But overall, the demand with Winchester is going to be up significantly versus last year. So I'll give you just one example. International military, we're looking at being twice what it was last year. So there is good momentum in these businesses. When you think about chlor-alkali, I'm not sure that I would put a lot of faith or confidence in CMA personally. We look at our system and the value that we're looking for and the demand that we want to supply at that value level, and we're seeing good demand. I don't want to say any more than that in terms of what the indices are printing, but we're seeing some differential pricing there and demand coming back at the value levels that we want. Thank you, Ken. And on just annual cadence of quarters, I mean, you're clearly talking about better second quarter. Do you think that step up between Q1 and Q2 then sustained at about the same rate in the second half, or is it improvement more second-half weighted? Anything you can say about sort of relatively Q2 versus second half? Yeah, so we're going to continue to see that step up. We saw a step up from Q4 to Q1. Q2, you're going to see a similar, maybe a slightly better step up from Q1 to Q2. As I said earlier, we're going to start to see in the back half of the year some demand come in just based on some of the requests that we're getting. So that's baked into that view. If you think about last year, last year, the first half was relatively strong, and the second half was relatively weak. I'm definitely not saying the second half is going to look like the first half of this year, but we're going to start coming out of this. That's our expectation, is that we'll start to see some of that recovery in the second half of this year. The early indications are that we're seeing that demand start to come back. Thank you, Ken. Sure. Thank you. Our next question comes from Patrick Cunningham from Citi. Please go ahead with your question. Hi. Good morning and congratulations and welcome, Ken. Ken, I just wanted to get a sense on capital allocation priorities versus that fourth pillar, writing the next chapter of Olin's success story. Olin's done a great job lifting the value of the ECU. How do you see yourself positioning Olin for sort of the next stage of sustainable growth? Well, thank you, Patrick. Like I said in the prepared comments, we're going to communicate more on that at the back end of the year, and we'll be announcing the specifics around that shortly. But the way that I think about it is we have a core capability with our commercial strategy, and I don't see that changing, even with a new strategy. I think that is a core part of our company now, and it's how we run our core businesses. We'll continue with that. But we're going to, as an executive team, step back and look at where can we go next? We're looking at the same data that you are, and we see the share price plateauing where it's at, and we're not satisfied with that. We want to continue to drive differential shareholder returns, and we're going to work in the coming weeks and months to define a compelling strategy that we think is going to help make the next step change in the future. Olin is a company that has a tremendous history and a lot of legacy businesses, and they've proven that they can run many different businesses. But you look at where we are today and where we have arrived today, what we have built now is something that we believe is sustainable. And we're going to look for things that we can build around this model, this operating model that we have. We're not going to be looking at doing things that are very far from our core. That's all I'm going to say at this time, but I'll just say stay tuned. Great. Thank you. Our next question comes from Jeffrey Zekauskas from J.P. Morgan. Please go ahead with your question. Thanks very much. Were your utilization rates in the first quarter much different than they were in the fourth quarter? My memory is maybe you're close to 50% in chlor-alkali. Is that right? And where do you expect them to be in the second quarter? Hi, Jeff. I hope you're doing well. Listen, we were a little bit above that. We were not at 50%. We were a little bit above that. And Q1 looked very similar to Q4. We were continuing in Q1 with the activation. We're going to see a slight step up in Q2 versus the utilization rates that we saw in Q1. But again, we're going to operate our system to match the demand that we see. We're not going to be pushing volume into the market. And like I said earlier, we are seeing some volume step up. In the normal seasonal uptick that you would see in the second quarter, we are starting to see that, and that's what we'll adjust our operating rates to meet that. Can you make a general comment on the rate of growth you're seeing or expect to see in chlorine versus caustic soda? Well, I think we're seeing a moderately better seasonal improvement in chlorine, which you would normally expect, right? We're getting into the water treatment season and bleach is coming back. So at this point in time, it's a little bit stronger in chlorine, but it's modest. It's not anything that's going to change how we're operating our model today. Okay. Great. Thank you very much. Thanks, Jeff. Our next question comes from Steve Byrne from BofA. Please go ahead with your question. Yes. Thank you. Maybe a downstream strategy question for you, Ken. Another year from now, the contract with Dow will come to a close. Are you more interested in shifting that capacity to other chlorine customers, or what is your interest in moving downstream into vinyls? Hi, Steve. Listen, it's early for me to give you any comments. Of course, we've got ideas and things that we're going to look at. But like I said earlier, we're going to take our time to look at where we think we can deliver the highest value, and that's not something that I'm prepared to give you an answer on specifically today. I know that we've talked about that in the past, and so it will certainly be one of the options that we looked at or that we will look at, but it's not anything right now that I'm willing to give you a view on. On the propellant availability issue, was this driven by an outage, and what are your options to offset that shortage problem? Yeah, that is really a function of significantly higher demand, as you can imagine. Like we had said earlier in the prepared remarks, commercial demand continues to be good, but military demand is significantly higher. And when you think about the supply chain for that propellant, there are very limited sources of that supply, let's put it that way. And the demand for that propellant is not just for small ammunition, which is what we're in. It's also for artillery and other components that are supporting the defense industry. So we are positioning ourselves with the scale that we have in terms of the buy to be able to secure some additional volumes, but it's still early. We're working that very hard, but I can't sit here and tell you that there would not be some potential risk in the coming months based on that availability of material. Very good. Thank you. Our next question comes from David Begleiter from Deutsche Bank. Please go ahead with your question. Thank you. Good morning, Ken, and congratulations as well on the new role. Ken, first, on customers, as you've gone around and talked with them, what has been the feedback, and what's been any source of consternation on their part in how you hope to improve that going forward? Well, thank you, Dave. Yeah, listen, I have talked to some customers, and I know that I'm not new to the industry. I know that there have been some things in the past that have created some tension in this industry over the last couple of years. I'll be honest with you, there are things that needed to happen in order to adjust the value of the products that we have. The reality is that going forward, we're going to be focusing on being able to continue to run our model and have good relationships with our customers. Even if we can't agree, we're going to continue to find ways to work together. I'm absolutely committed to that, and so is the executive team. Very good. Just on Winchester, I know this is a tough question to answer, but is Olin the best owner of the Winchester business? Well, Dave, I'll tell you, I am a very big fan of the Winchester business. I think that this is a brand that is undervalued today as part of our company. That's my view. So we're going to be taking a look at that as we go forward to find a way to get higher value for having that business as part of Olin. And that will be a portfolio is always something that you're going to look at going forward, but we are very happy with the Winchester business and believe that it's something that we can find the path to get a higher value for that, and we're committed to doing that. Thank you. Our next question comes from Duffy Fischer from Goldman Sachs. Please go ahead with your question. Yeah. Good morning. I was wondering if you could just get a little bit more clarity on the Q2 walk. So I think, Ken, you made a comment that you think the delta will be roughly the similar to maybe a little bit better than the move from Q4 to Q1. That was $32 million. So just to put a number, $285 million, is that about the right way to think about the over/under on where we're shooting for Q2? Yeah. So definitely, look, the walk is really we're going to continue to see the price momentum that we saw coming out of Q1. That's going to continue into Q2 for chlor-alkali and those businesses. We will see seasonal demand uptick there as well. For epoxy, we're looking at seeing improvement in terms of our mix and some volume improvement, but we will see an improvement in mix. We're also going to see continued positive impact from the restructuring in Q2. We're going to see that momentum continue. And then with Winchester, like we had said previously in the remarks, we're expecting that to be relatively flat. So it's a combination of pricings, better mix in the second quarter versus the first quarter. But to range it, yeah, it's going to be about the same as a step up from Q4 to Q1, maybe a little bit better than that. That's the way I'd put it. Okay. Thanks. And then just to clarify, if your 1.3 ends up being right this year, you guys do not need to pay down any more structural debt to keep your investment-grade rating, and so therefore, all that excess cash can go to share buybacks. Did I hear that right? Well, that's going to continue to be our priority. Yeah. I don't know, Todd, if you want to add anything to that. Yeah. Duffy, we have an investment-grade balance sheet today. We have one of the three rating agencies that rate us investment-grade. Where our results are and expected to be for the year, our debt level as where we ended last year is consistent with our expectation for the end of this year. So we don't need to have any structural debt repayment. Great. Thank you, guys. Our next question comes from Josh Spector from UBS. Please go ahead with your question. Hi. Thanks for taking my question and echo my congrats, Ken. So I just wanted to follow up again on the guidance. So if we're talking about 2Q less than $300 million, I guess to hit that range, you're going to need a quarter greater than $400 million probably later in the year. I mean, it seemed like your answers before was that you expect pricing to move up through the year to do that, but you've also talked about increasing demand. So if you think about bridging that $100 million step up from, call it, 2Q to, let's say, 4Q, how would you bracket that between assumptions on pricing versus volumes? Well, first, you're correct with your math, and I'm not giving you a specific number around Q2, so I want to be careful with that. I would put it more of a range that would say, again, it could be slightly better than the step up from Q4. And a lot of that is going to depend on the volume recovery that we see coming. The mix between volume and price is probably a little bit more volume coming back in PVC, but we've got the momentum from pricing that we saw at the end of Q1. So that combined with continued pricing step-ups in chlor-alkali is going to be the biggest driver there. The bigger driver for epoxy is going to be mix. It's going to be the improved margin with the portfolio that we're going to see in Q2. All right. Thanks, Ken. And if I could just ask, I mean, there's been some comments in the news about the St. Gabriel mural ramp-up and maybe some choppiness there. Does that have any headwind in 2Q that you call out or in 1Q at all? No. Yeah. We've got a system that's operating relatively low utilization rates, and so we're able to flex our system to be able to make up for any shortfalls at whatever sites may have an upset. We can adjust for that in our system. So I don't expect there to be anything to impact our Q2 results there. Okay. Thank you. Our next question comes from Arun Viswanathan from RBC Capital Markets. Please go ahead with your question. Great. Thanks. I just wanted to ask a couple of questions. Maybe first on and congratulations, Ken. Good to hear your voice again. So just on the Parlay index, that looks like that ticked down in the quarter. Was that maybe due to your own efforts of selling into the market, or was it maybe also an inflection point in volumes, or how would you kind of characterize the Parlay activity? Thanks. Yeah. Thanks, Arun. I mean, listen, that's a reflection of what we have talked about, which is the market around caustic is tighter than people believe. I can tell you that our inventory levels are very low, and we believe that the industry is low as well. And so you're seeing a little bit of an adjustment there in those Parlay volumes. And be careful with that because those volumes are going to move around based on things that are much more broad than just our portfolio moves, right? But we do see the market being tighter for caustic, and I think that's what you're seeing reflected in that Parlay volume. Great. And then just given the expectation that you will be exiting the second half or maybe the second half EBITDA, if you do hit that $1.3 billion plus, will be on the order of $700 million-$800 million, is that kind of a fair starting point for first half next year? Would that really be an indication that volumes are approaching a more normal level? And I guess my only concern there would be, would that require epoxy also to get materially better, or can you get there with mainly chlor-alkali improvement? Yeah. Thanks, Arun. Listen, I would say that to start talking about what's going to happen that far out with the amount of uncertainty in the world today would not be prudent, right? I mean, we've got a lot of things that are going to happen between now and even the fourth quarter. We need to see how that plays out and how the global economy develops. But again, in the short term, we are seeing improvement in demand. Beyond that, it's really too early to make any calls what the first half of next year might look like. Okay. And then one quick one, if I could. Just on the shareholder returns, what's kind of a comfortable floor of buybacks that we should assume for this year, maybe in the $500 million-$600 million range? Or how should we frame that? Thanks. Well, I mean, what we've said previously is we'll be a steady buyer of our shares. I'm not going to give you any prediction now on the amount that we would purchase. Todd, do you want to add anything to that? You saw the level of purchases we did in the first quarter, roughly $105 million. Given our levered free cash flow forecast and we're a steady buyer, you can make your own assumptions. That's really our primary use of levered free cash flow other than our regular dividend that we pay. That's where you would expect that to be used, Arun. Thanks. Thanks, Arun. Our next question comes from Mike Sison from Wells Fargo. Please go ahead with your question. Hey. Nice start to the year, Ken. Welcome on board. Just curious, and I know it might be a little bit early to comment, but if you think about what Olin's mid-cycle EBITDA potential and maybe peak EBITDA potential, do you have any thoughts of maybe where or how you could sort of get there and what levels those EBITDA earnings could get to? Well, thank you, Mike. Listen, what I will say is that Olin has been very successful in resetting the cycle, which is great to see. Where we're at now in the trough is above the prior peak, and we do believe that is durable. I don't have a view that I would give you right now in terms of the mid-cycle level for Olin. Maybe we'll get to that when we have our investor day later this year, but nothing really to elaborate on at this point. Understood. Yeah. Looking forward to that endless day in Cleveland, right? No, I'm joking. But sort of a follow-up in terms of sort of the setup for 2Q and second half of the year. So it sounds if the step up in 2Q versus 1Q is better than the fourth versus the first versus the fourth, it doesn't sound like you'll be above $300 million. I know you don't want to get specific guidance, but I guess part of the question is, what operating rate do you need to get to in the second half to sort of get to that much higher EBITDA level to do the $1.3 billion or so for the full year? Well, again, I know we want to focus on operating rates, but there's more than just the operating rates for chlor-alkali that we need to think about. There will be some increase in the operating rate, obviously, as we see the demand come back. But don't forget about the important role that our Winchester business is going to play. We're going to see that improve through the year. We're going to see epoxy continue to improve through the year. So it's more than just focusing on that operating rate. We will adjust the operating rate to match the demand that we see. And obviously, if the demand is coming back with our inventories being low, operating rates will step up. But that's only one part of that equation to get to the higher level in the back half of the year. Thank you. Sure. Thanks. Our next question comes from Matthew Blair from TPH. Please go ahead with your question. Good morning and congrats, Ken. There's been a lot of commentary on just the positive demand trends that you're seeing. Could you provide any more color on which end markets are relatively stronger and which end markets are relatively weaker, just thinking about areas like pulp and paper, alumina, and then, I guess, more of the construction side? Yeah. Well, like we had said in the prepared remarks, we are seeing improving demand in agriculture, titanium dioxide, polyurethanes, which go into a lot of different end markets. I would say, in general, the area that we're not seeing the improvement yet is around construction. That's a very big driver for our businesses. So things like electronics and even wind energy, we're going to start to see some improvement there. But a big market for us is construction, and we're not seeing improvement in that market yet. And I'll just comment related to that is China and what we see happening in China. There have been some very small improvements that we see in China, but we're not seeing anything structural improved there yet. And for us to really see a global improvement in some of our commodity flows, we need to see China start to grow more. That's still something we're watching very closely is what's happening in that market. Okay. I guess the tepid numbers in construction, does that help explain why spot EDC prices are a little bit lower in Q2 versus Q1, or are there other dynamics at play? I'm sorry. You said spot what prices? Spot EDC. EDC. Okay. I'm sorry. I didn't follow what you were saying. Yes. So I think what we saw in the first quarter, there was some volume getting pushed into the market just because of operating upsets. We actually saw some improvement in our portfolio and pricing there, but I think that is going to normalize as the assets that are producing get back to a normal level of operations and not trying to adjust for an upswing that's not necessarily as strong as what was thought previously. Great. Thanks for your comments. Sure. Thank you, Matthew. Our next question comes from Kevin McCarthy from Vertical Research Partners. Please go ahead with your question. Thank you and good morning. Ken, welcome. Good to hear your voice as well. My question relates to energy. Obviously, natural gas prices have been very favorable lately south of $2 per BTU. Can you talk about Olin's hedge positioning? To what degree have you locked in these low prices, or might the exposure be more freely floating as we think about how ECU values or margins may trend moving forward? Thank you, Kevin. Yeah. So we've talked about this before. Our hedge strategy is we tend to hedge a pretty high percentage in the current quarter, and then that will gradually step down in the next three quarters. So in the first quarter, we were very highly hedged in terms of a percentage of our portfolio, and we continue to do that in the second quarter. So we won't see as much benefit in the lower energy prices that you see today in the market. We will see some of that. But our hedging strategy is really to avoid the pain of the peaks and the shocks that you see. Todd, do you want to add anything to that? I see. Yeah. Kevin, as you saw from Q4 to Q1, chlor-alkali had favorable cost, and you should expect that to continue into Q2. Part of that includes power. So even though we are a hedger, the lower power prices, natural gas costs will flow through our system, albeit not necessarily on a spot basis, but will flow into our system favorable from a cost perspective. Okay. That's very helpful. And then, Todd, I wanted to clarify some of the commentary around levered free cash flow. I think you were at $545 million last quarter. Sounds like, if I did my math correctly, maybe you're tracking a little bit less than that, maybe closer to $500 million. And I heard you call out tax timing and long-term energy agreement. I guess my questions would be, what exactly changed over the last two or three months, and has there been any change in what I would call kind of the normal drivers of free cash flow, such as working capital and CapEx and so forth? Yeah. Kevin, from a levered free cash flow perspective, I think really our assumptions were virtually unchanged. We did have a slight change in the assumption page where we said we thought the total amount that we were going to spend on the Gulf Coast Power contract payments to be $50 million. Now that the person that's doing that and we have to pay to, we have a relatively final number now for 2024, so we think that's going to be $50 million. We had estimated that 25-50 before, so it'll come in at the high end. Other than that, I don't think there was any substantive changes to our outlook on levered free cash flow. Got it. Thank you so much. Our next question comes from Vincent Andrews from Morgan Stanley. Please go ahead with your question. Thank you and good morning and congrats to you, Ken, very well deserved. If I could just ask you two things. One, could you give a little bit more color on the orders that you're already getting for the back half of the year? Are they coming from any specific end markets, and what's driving that so far in advance? And then secondly, if I could ask you just about St. Gabriel and just sort of operating issues in general, is there any tension between wanting to be a reliable operator and having plants down for extended periods of time in terms of the risks of them coming back online easily and without any incremental maintenance costs? Hi, Vincent. Thank you. So listen, the orders that we're seeing in the second half are actually pretty broad in terms of the end markets that we see. We're even seeing some customers who have had assets down that are looking to restart. So it's not just one place that we're seeing that. It's pretty broad, which gives us some pretty good confidence in terms of that demand uptick that we're talking about. I get your question around the reliability topics and St. Gabriel. We will do what we need to do to operate safely first, and we want to have the assets available when we need them. And that means that when they need to run, they will run. And that's what you've seen happen with St. Gabriel. We took it down. We have restarted that asset, and we're going to continue to focus on operating safely and doing what we have to do to do that, but make sure that when we need that asset to operate, it will operate. And one of the things that I've seen just traveling around to the sites - and I've visited many of our chlor-alkali sites in the U.S. - is the strong commitment to that. I was really impressed with the condition of the assets visiting the sites. So very happy with that, and I'll continue to support our manufacturing team to be ready and to be able to operate the assets at the demand level we need and the value that we need. Our next question comes from Frank Mitsch from Fermium Research. Please go ahead with your question. Good morning. Yes, let me echo my congrats, Ken. Nice to reconnect. One of the interesting things is chlorine prices in the first quarter, according to the consultants, ticked down a little bit, but it was up in your system. I understand that some of that may be contract resets. Can you talk about the interplay between contract resets and maybe other pricing for chlorine that led chlorine prices to be up in the Olin system? Yeah. Thanks, Frank. I appreciate the question. Good to reconnect. Listen, I will tell you that I don't put a lot of faith in those indices. I just don't. I look at what we have in our system, and you know how we operate. We operate to meet the demand at the value that we want, and that's basically the model that we have. We are not going to give away our products. We're going to make sure that we get the right value for the products that we produce, and we'll continue to focus on matching the demand at the weak side of the ECU. And that's the result, is what you see in the numbers for us. We're going to be the ones that are focusing on value, and that's not going to change. Terrific. The guests that you heard were coming out of CMA and ICIS, etc. You get it. You get it. But it is what it is. Great. And then just to follow up also on chlorine end use, I mean, you did talk about B&C not seeing a big recovery there and so forth. Do you have any in the $1.3 billion for 2024, do you have any measure of recovery in the construction markets in the back half of the year? And I guess the reason why I ask that is, obviously, the flavor of the month is interest rates aren't going to be cut anytime soon, so people are concerned about construction in general. Can you talk about what may or may not be embedded into your full-year guide from those markets? Yeah. I mean, listen, for construction, no. We're not baking in any kind of significant recovery there. You look at the housing starts and the permits, and we don't see the momentum in housing that would support us baking in any optimism in that market. So really, like I said earlier, it's more of a broad-based, consumer-driven demand with a lot of different areas that we see signs of hope in, but I wouldn't say construction is one of those yet. Terrific. Thank you so much. Yep. Thank you. Once again, if you would like to ask a question, please press star and one. Our next question comes from Roger Spitz from Bank of America. Please go ahead with your question. Thanks very much. Good morning. When you said earlier the free cash flow yield of 10%, are you saying that operating cash flow, less CapEx and before dividends, would be circa $130 million for 2024? Do I understand that correctly? Todd, do you want to take that? Yeah. Roger, when we talk about, I said specifically our levered free cash flow yield, which is consistent with the metric that we've been using, and we would say that's probably in the 10% range for the year, maybe a little higher than that as we sit with the price today. Okay. And secondly, I'm looking at slide 12, lower right, where you're showing caustic being on the stronger side in the first quarter and second quarter of 2024. Next to it on the presentation, it's showing that caustic is actually down sequentially. I guess maybe I don't fully understand the stronger side when caustic soda pricing is falling. Well, again, this is relative. You can't think about it in absolute terms. It's relative to what we see in chlorine versus caustic market momentum. And we have seen caustic market momentum actually be more positive. I talked about this before where actually inventory levels are low, ours are very low. We've seen pricing moving up in caustic, and we're just starting to see some recovery in chlorine. So chlorine, from our perspective, is still the weaker side. Got it. Thank you very much. Yep. Thank you, Roger. Ladies and gentlemen, in showing no further questions, this will conclude our question-and-answer session. I'd like to turn the conference call back over to Ken Lane for closing comments. Well, thank you very much, Jamie, and thank you all for participating in the call today. I wish you all a safe and relaxing weekend. Ladies and gentlemen, thank you for attending today's presentation. You may now disconnect your lines.